News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Gastric Cancer Treatment
February 26, 2025
Camrelizumab Combination Demonstrates High Success Rates in Tumor Removal and Long-Term Survival in Gastric or Gastroesophageal Junction Cancer
Charles H. Weaver, MD
October 23, 2024
FDA Approves Vyloy Combination for Gastric or Gastroesophageal Junction Adenocarcinoma
Charles H. Weaver, MD
October 8, 2024
Bemarituzumab Combination Shows Potential for Advanced Gastric Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
